Ocumension Therapeutics (1477.HK)

HKD 5.55

(0.36%)

Net Income Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual net income in 2023 was -379.78 Million CNY , up 5.68% from previous year.
Ocumension Therapeutics's latest quarterly net income in 2023 FY was -379.78 Million CNY , up 5.68% from previous quarter.
Ocumension Therapeutics reported an annual net income of -402.64 Million CNY in 2022, down -198.74% from previous year.
Ocumension Therapeutics reported an annual net income of -134.78 Million CNY in 2021, up 94.03% from previous year.
Ocumension Therapeutics reported a quarterly net income of -85.69 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ocumension Therapeutics reported a quarterly net income of -379.78 Million CNY for 2023 FY, up 5.68% from previous quarter.

Annual Net Income Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Net Income of Ocumension Therapeutics (2023 - 2018)

Year	Net Income	Net Income Growth
2023	-379.78 Million CNY	5.68%
2022	-402.64 Million CNY	-198.74%
2021	-134.78 Million CNY	94.03%
2020	-2.25 Billion CNY	-73.43%
2019	-1.3 Billion CNY	-526.95%
2018	-207.6 Million CNY	0.0%

Year	Net Income	Net Income Growth
2023 Q2	-104.2 Million CNY	0.0%
2023 Q4	-85.69 Million CNY	0.0%
2023 FY	-379.78 Million CNY	5.68%
2023 Q1	-104.2 Million CNY	0.75%
2023 Q3	-85.69 Million CNY	17.76%
2022 Q1	-96.33 Million CNY	-1.2%
2022 Q2	-96.33 Million CNY	0.0%
2022 Q4	-104.98 Million CNY	0.0%
2022 Q3	-104.98 Million CNY	-8.98%
2022 FY	-402.64 Million CNY	-198.74%
2021 Q1	-34.8 Million CNY	86.69%
2021 FY	-134.78 Million CNY	94.03%
2021 Q4	-95.19 Million CNY	0.0%
2021 Q3	-95.19 Million CNY	-173.5%
2021 Q2	-34.8 Million CNY	0.0%
2020 Q3	-261.54 Million CNY	69.97%
2020 Q2	-870.88 Million CNY	0.0%
2020 FY	-2.25 Billion CNY	-73.43%
2020 Q1	-870.88 Million CNY	-62.12%
2020 Q4	-261.54 Million CNY	0.0%
2019 Q3	-537.17 Million CNY	-351.47%
2019 FY	-1.3 Billion CNY	-526.95%
2019 Q4	-537.17 Million CNY	0.0%
2019 Q1	-118.98 Million CNY	0.0%
2019 Q2	-118.98 Million CNY	0.0%
2018 FY	-207.6 Million CNY	0.0%

Peer Net Income Comparison of Ocumension Therapeutics

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	635.847%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	2301.664%